AU6549186A
(en)
*
|
1985-10-24 |
1987-05-19 |
Biotechnology Research Partners Limited |
Blood tests diagnostic for hypertension
|
GB8606719D0
(en)
*
|
1986-03-19 |
1986-04-23 |
Lister Preventive Med |
Genetic probes
|
FR2603047B1
(fr)
*
|
1986-08-19 |
1990-03-02 |
Vassart Gilbert |
Sonde d'hybridation pour la detection de sequences nucleotidiques polymorphes contenues dans un echantillon d'adn humain ou animal, procede de detection de sequences d'adn polymorphes utilisant une telle sonde, ses applications biologiques
|
EP0269260A3
(en)
*
|
1986-10-29 |
1988-06-22 |
Biotechnology Research Partners, Ltd. |
Apoai-ciii-aiv, apoaii apob, apoci, and ldl receptor polymorphisms for genetic fingerprinting and predictive of atherosclerosis
|
EP0294098A1
(en)
*
|
1987-05-29 |
1988-12-07 |
City Of Hope |
Synthetic DNA probes
|
GB8716367D0
(en)
*
|
1987-07-10 |
1987-08-19 |
Reeders S T |
Genetic identification
|
US5206137A
(en)
*
|
1988-09-08 |
1993-04-27 |
Lifecodes Corporation |
Compositions and methods useful for genetic analysis
|
US5091302A
(en)
*
|
1989-04-27 |
1992-02-25 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
|
US6110742A
(en)
*
|
1992-04-15 |
2000-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Synthetic antisense oligodeoxynucleotides targeted to AChE
|
JP3465903B2
(ja)
*
|
1992-07-31 |
2003-11-10 |
ガーヴァン インスティチュート オブ メディカル リサーチ |
作動因子における対立遺伝子の変動の評価
|
US5843652A
(en)
*
|
1993-05-21 |
1998-12-01 |
Lockheed Martin Energy Systems, Inc. |
Isolation and characterization of Agouti: a diabetes/obesity related gene
|
US6310034B1
(en)
|
1993-05-21 |
2001-10-30 |
Ut-Battelle, Llc |
Agouti polypeptide compositions
|
WO1995034640A1
(en)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US6309843B1
(en)
|
1994-10-25 |
2001-10-30 |
The Curators Of The University Of Missouri |
Glycoprotein for use in determining endometrial receptivity
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US6653134B2
(en)
*
|
1995-03-28 |
2003-11-25 |
Cp Hahnemann University |
Isolated stromal cells for use in the treatment of diseases of the central nervous system
|
US5777093A
(en)
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5686246A
(en)
*
|
1995-08-03 |
1997-11-11 |
Kornman; Kenneth S. |
Detecting genetic predisposition to periodontal disease
|
CA2227306A1
(en)
*
|
1995-09-01 |
1997-03-27 |
Ramot-University Authority For Applied Research And Industrial Developme Nt Ltd. |
Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection
|
US5994061A
(en)
*
|
1995-09-29 |
1999-11-30 |
Queen's University At Kingston |
DNA constructs and methods for screening for increased expression of human apo AI gene
|
NZ331041A
(en)
*
|
1996-01-17 |
2001-06-29 |
Timothy David Spector |
In vitro method for diagnosis of osteoporosis, atherosclerosis, cancer and immune disorders and medicaments
|
ATE352614T1
(de)
*
|
1996-12-12 |
2007-02-15 |
Yissum Res Dev Co |
Synthetische antisense oligodeoxynukleotide und diese enthaltende pharmazeutische zusammensetzungen
|
US6210877B1
(en)
|
1997-03-10 |
2001-04-03 |
Interleukin Genetics, Inc. |
Prediction of coronary artery disease
|
US6720141B1
(en)
|
1999-11-01 |
2004-04-13 |
Interleukin Genetics, Inc. |
Diagnostics and therapeutics for restenosis
|
US6524795B1
(en)
*
|
1997-03-10 |
2003-02-25 |
Interleukin Genetics, Inc. |
Diagnostics for cardiovascular disorders
|
US7820383B2
(en)
*
|
1997-03-10 |
2010-10-26 |
Interleukin Genetics, Inc. |
Method for diagnosing myocardial infarction
|
GB9723553D0
(en)
*
|
1997-11-07 |
1998-01-07 |
Duff Gordon W |
Prediction of the risk of chronic obstructive airway disease
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
AU9110798A
(en)
*
|
1997-08-21 |
1999-03-08 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US6746839B1
(en)
|
1998-01-12 |
2004-06-08 |
Interleukin Genetics, Inc. |
Diagnostics and therapeutics for an obstructive airway disease
|
US20010055809A1
(en)
*
|
1998-01-30 |
2001-12-27 |
Harpal S. Mangat |
Extending tissue preservation
|
CN1302107C
(zh)
|
1998-01-30 |
2007-02-28 |
吉倪塞思技术公司 |
与硫氧还蛋白或硫氧还蛋白还原酶基因互补的寡核苷酸序列以及将其用于调节细胞生长的方法
|
US6733967B1
(en)
|
1998-04-21 |
2004-05-11 |
Interleukin Genetics, Inc. |
Fetal testing for prediction of low birth weight
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(en)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
WO2000006696A2
(en)
*
|
1998-07-30 |
2000-02-10 |
University Of South Florida |
Method for the modulation of function of transcription factors
|
JP2003523166A
(ja)
*
|
1998-09-29 |
2003-08-05 |
ガミダ セル リミテッド |
幹細胞および前駆細胞の増殖と分化を制御する方法
|
US20040235107A1
(en)
*
|
1999-01-29 |
2004-11-25 |
Ramot At Tel Aviv University Ltd. |
Biosynthesis of TA antibiotic
|
EP1026248A3
(en)
|
1999-01-29 |
2002-09-18 |
RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. |
Gene cluster
|
JP4523169B2
(ja)
|
1999-02-04 |
2010-08-11 |
プルリステム リミテッド |
造血幹細胞および/または前駆細胞を維持および増加するための方法および装置
|
US20050169896A1
(en)
*
|
1999-05-14 |
2005-08-04 |
Henry Ford Health System |
Bone marrow transplantation for treatment of stroke
|
AU780994B2
(en)
*
|
1999-05-14 |
2005-04-28 |
Henry Ford Health System |
Bone marrow transplantation for treatment of stroke
|
US8017112B2
(en)
|
1999-05-14 |
2011-09-13 |
Henry Ford Health System |
Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
US7655423B2
(en)
*
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
JP2003532622A
(ja)
*
|
1999-06-14 |
2003-11-05 |
ヘンリー フォード ヘルス システム |
神経発生を誘導する一酸化窒素ドナー
|
EP1190082A4
(en)
*
|
1999-06-25 |
2003-07-02 |
Yissum Res Dev Co |
PROCESS FOR INDUCING ANGIOGENESIS USING MICROORGANES
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
AU2001225441A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Agricultural Research Organization The Volcani Center |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
US6225069B1
(en)
|
2000-02-29 |
2001-05-01 |
The Board Of Trustees Of The University Of Arkansas |
Methods to identify genetic predisposition to alzheimer's disease
|
EP2316950A1
(en)
|
2000-03-27 |
2011-05-04 |
Technion Research and Development Foundation, Ltd. |
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
DK1315519T3
(da)
|
2000-08-08 |
2011-04-11 |
Technion Res & Dev Foundation |
Farmaceutiske sammensætninger og fremgangsmåder, der kan anvendes til behandling af cancer eller leverfibrose
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1337670A4
(en)
|
2000-08-16 |
2004-07-14 |
Whatman Inc |
LEUCOCYTAL REDUCTION FILTERING DEVICES FOR TRANSFUSION MEDICINE USED AS A SOURCE OF GENETIC MATERIAL FOR GENOTYPING STUDIES
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
EP1379127B1
(en)
*
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
PT2186530E
(pt)
|
2000-11-17 |
2013-08-02 |
Vascular Biogenics Ltd |
Promotores que apresentam uma especificidade das células endoteliais e os métodos de usar os mesmos
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
EP1463811A2
(en)
*
|
2001-01-17 |
2004-10-06 |
Ramot at Tel Aviv University Ltd. |
Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
EP1377156A4
(en)
*
|
2001-03-22 |
2007-08-29 |
Scentgene Pollination Ltd |
METHOD FOR INCREASING ENTOMOPHILIA
|
JP3945993B2
(ja)
*
|
2001-03-29 |
2007-07-18 |
富士通株式会社 |
半導体記憶装置
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
US7125664B2
(en)
*
|
2001-06-20 |
2006-10-24 |
Dahlia Minc-Golomb |
Method for identifying genes that are upstream regulators of other genes of interest
|
US20050022269A1
(en)
*
|
2001-07-19 |
2005-01-27 |
Joseph Hirschberg |
Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
CA2465672A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Henry Ford Health System |
Cardiac transplantation of stem cells for the treatment of heart failure
|
JP4173446B2
(ja)
|
2001-10-19 |
2008-10-29 |
ヴァスキュラー バイオジェニックス リミテッド |
血管形成の標的化されたダウンレギュレーションおよび抗ガン治療のためのポリヌクレオチド構築物および薬学的組成物および方法
|
WO2003048298A2
(en)
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20070021345A1
(en)
|
2003-06-30 |
2007-01-25 |
Ehud Gazit |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
EP1485464A4
(en)
*
|
2002-03-18 |
2006-11-29 |
Gamida Cell Ltd |
METHODS OF INDUCING DIFFERENTIATION IN EX VIVO EXPANDED STEM CELLS
|
IL164191A0
(en)
*
|
2002-03-26 |
2005-12-18 |
Nanocyte Inc |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosme tic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue nanocyte inc.
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003231912A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Tel Aviv Medical Center Research Development Fund |
Methods of detecting and treating prostate cancer
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
ES2449115T3
(es)
|
2002-08-01 |
2014-03-18 |
Yeda Research And Development Co., Ltd. |
Método y composición para proteger el tejido neuronal de lesiones inducidas por niveles de glutamato elevados
|
US20070065830A1
(en)
*
|
2002-09-04 |
2007-03-22 |
Children's Hospital Medical Center Of Akron, Inc. |
Cloning multiple control sequences into chromosomes or into artificial centromeres
|
WO2004026109A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Wayne State University |
Molecular targets of cancer and aging
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
AU2003278578A1
(en)
|
2002-10-30 |
2004-05-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
CN101297789B
(zh)
|
2002-12-12 |
2013-01-02 |
R.B.T.(洛东生物科技)有限公司 |
木质素过氧化物酶的生产方法及其在皮肤和毛发增亮中的应用
|
PT2457999T
(pt)
|
2002-12-16 |
2019-01-28 |
Technion Res & Dev Foundation |
Sistema de cultura para células estaminais pluripotentes
|
CN1780921B
(zh)
|
2003-01-02 |
2010-12-08 |
拉帕波特家族医学研究院 |
用于检测触珠蛋白表型的试剂、试剂盒及其用途
|
EP1583713B1
(en)
*
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
US7786071B2
(en)
|
2003-03-04 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same
|
CA2517959A1
(en)
*
|
2003-03-07 |
2004-09-16 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of pi 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
US7524938B2
(en)
|
2003-04-04 |
2009-04-28 |
Yeda Research And Development Co., Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
CA2978152C
(en)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
|
AU2005234725B2
(en)
*
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
WO2004111183A2
(en)
*
|
2003-06-19 |
2004-12-23 |
Evogene Ltd. |
Plant trichome-specific promoter and leucoplast signal sequence
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
WO2005012256A1
(en)
|
2003-07-22 |
2005-02-10 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
CN102120031B
(zh)
|
2003-08-07 |
2012-12-05 |
希尔洛有限公司 |
用于加速伤口愈合的药物组合物和方法
|
JP2007518394A
(ja)
*
|
2003-08-14 |
2007-07-12 |
ザ バイオ バランス コーポレイション |
細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
|
GB2404981A
(en)
*
|
2003-08-15 |
2005-02-16 |
Univ Geneve |
Diagnostic method for stroke
|
US7517647B2
(en)
*
|
2003-09-29 |
2009-04-14 |
New York University |
Genetic screen for bioactive peptides
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
CA2541535C
(en)
|
2003-10-07 |
2013-12-10 |
Yeda Research And Development Co. Ltd. |
Antibodies to nik, their preparation and use
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
CN1918281A
(zh)
*
|
2003-10-23 |
2007-02-21 |
辉瑞产品公司 |
牙周病疫苗
|
WO2005051423A2
(en)
|
2003-11-30 |
2005-06-09 |
Yeda Research And Development Co. Ltd |
Methods and agents for immune modulation and methods for identifying immune modulators
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
WO2005061018A1
(en)
|
2003-12-22 |
2005-07-07 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring protein backbone
|
EP2228369A1
(en)
|
2003-12-23 |
2010-09-15 |
Astex Therapeutics Ltd. |
Pyrazole derivatives as protein kinase modulators
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
AU2005206388A1
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
EP2330111A3
(en)
|
2004-01-30 |
2011-08-17 |
Quark Pharmaceuticals, Inc. |
Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
|
WO2005084699A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
Alk7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
EP1766058A4
(en)
*
|
2004-06-14 |
2008-05-21 |
Evogene Ltd |
POLYNUCLEOTIDES AND POLYPEPTIDES INVOLVED IN THE DEVELOPMENT OF PLANT FIBERS AND METHOD OF USE THEREOF
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
US20090181092A1
(en)
*
|
2004-07-16 |
2009-07-16 |
Spinal Restoration, Inc. |
Methods for Treating Joints and Discs with a Carrier Matrix and Cells
|
WO2006013552A2
(en)
*
|
2004-08-02 |
2006-02-09 |
Ramot At Tel Aviv University Ltd. |
Articles of peptide nanostructures and method of forming the same
|
US7786086B2
(en)
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
WO2006030442A2
(en)
*
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
DK1799269T3
(da)
|
2004-09-28 |
2016-10-03 |
Quark Pharmaceuticals Inc |
Oligoribonukleotider og fremgangsmåder til anvendelse deraf til behandling af alopeci, akut nyresvigt og andre sygdomme
|
EP1809751B1
(en)
|
2004-09-29 |
2010-09-01 |
CollPlant Ltd. |
Collagen producing plants and methods of generating and using same
|
EP1809374A4
(en)
*
|
2004-10-12 |
2008-09-10 |
Closed Loop Therapies Ltd |
IMPLANTABLE METHODS AND DEVICES FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
GB0428082D0
(en)
*
|
2004-12-22 |
2005-01-26 |
Welcome Trust The Ltd |
Therapeutic compounds
|
US8110573B2
(en)
|
2004-12-30 |
2012-02-07 |
Astex Therapeutics Limited |
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
|
EP1872604A4
(en)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
COMMUNICATION NETWORK SYSTEM AND METHODS OF USE
|
US8375327B2
(en)
*
|
2005-01-16 |
2013-02-12 |
Zlango Ltd. |
Iconic communication
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
MX2007008781A
(es)
|
2005-01-21 |
2007-09-11 |
Astex Therapeutics Ltd |
Compuestos farmaceuticos.
|
BRPI0606480A
(pt)
|
2005-01-21 |
2008-03-11 |
Astex Therapeutics Ltd |
compostos farmacêuticos
|
ES2562406T3
(es)
|
2005-01-31 |
2016-03-04 |
Realbio Technologies Ltd. |
Dispositivo capilar de flujo lateral de reacción multietapa
|
JP5432455B2
(ja)
|
2005-02-25 |
2014-03-05 |
ザ ステート オブ イスラエル、ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント、アグリカルチュラル リサーチ オーガナイゼイション、(エー.アール.オー.)、ボルカニ センター |
炎症治療用の果実細胞培養抽出物
|
RS52715B
(en)
|
2005-04-13 |
2013-08-30 |
Astex Therapeutics Limited |
HYDROXYBENZAMIDE DERIVATIVES AND THEIR APPLICATIONS AS HSP90 INHIBITORS
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
US9943481B2
(en)
|
2005-05-26 |
2018-04-17 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
ES2524996T3
(es)
|
2005-06-16 |
2014-12-16 |
Ramot At Tel Aviv University Ltd. |
Células aisladas y poblaciones que comprenden a las mismas para el tratamiento de enfermedades del SNC
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US9051379B2
(en)
|
2005-07-07 |
2015-06-09 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
|
CN101273130B
(zh)
*
|
2005-07-07 |
2012-05-30 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于下调h19的核酸物质及其使用方法
|
CA2615218A1
(en)
|
2005-07-18 |
2007-01-25 |
Protalix Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
EP1928479B1
(en)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
RS57549B1
(sr)
|
2005-08-26 |
2018-10-31 |
Ares Trading Sa |
Proces za pripremu glikoziliranog interferona beta
|
SG177946A1
(en)
|
2005-08-29 |
2012-02-28 |
Technion Res & Dev Foundation |
Media for culturing stem cells
|
DE602006014009D1
(de)
*
|
2005-09-22 |
2010-06-10 |
Yissum Res Dev Co |
Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
|
EP1973928A2
(en)
*
|
2005-10-11 |
2008-10-01 |
Ramot at Tel-Aviv University Ltd. |
Self-assembled fmoc-ff hydrogels
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
EP1940217A4
(en)
|
2005-10-24 |
2009-11-11 |
Evogene Ltd |
ISOLATED POLYPEPTIDES, POLYNUCLEOTIDES ENCODING THESE, TRANSGENIC PLANTS EXPRESSING THESE AND METHODS USING SAME
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
KR20080072748A
(ko)
|
2005-11-29 |
2008-08-06 |
가미다-셀 리미티드 |
줄기세포 귀소 및 생착을 향상시키는 방법
|
EP1981910B1
(en)
|
2006-01-13 |
2013-06-26 |
A Chan Holding B.V. |
Method for identifying inhibitor of the glypican-sclerostin interaction
|
WO2007080559A2
(en)
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Iconic communication
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US7553940B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP1989554A1
(en)
|
2006-02-06 |
2008-11-12 |
Rappaport Family Institute For Research in the Medical Sciences |
Methods and kit for diagnosing t1dm
|
EP1991852B1
(en)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Methods for identifying a cell phenotype
|
CA2646384C
(en)
|
2006-03-23 |
2020-03-24 |
Pluristem Ltd. |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
EP2004858A4
(en)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
METHOD AND KITS FOR DETERMINING AN INVESTMENT TO WARFARINE RESISTANCE
|
US20070231449A1
(en)
*
|
2006-03-30 |
2007-10-04 |
Nutracea |
Non-starchy rice bran polysaccharides
|
EP3719018A1
(en)
|
2006-04-25 |
2020-10-07 |
Astex Therapeutics Ltd |
Purine and deazapurine derivatives as pharmaceutical compounds
|
AU2007245495A1
(en)
|
2006-04-26 |
2007-11-08 |
Astex Therapeutics Limited |
Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
EP2046109A4
(en)
|
2006-07-20 |
2010-01-06 |
Yeda Res & Dev |
PHOTOSYNTHETIC ORGANISMS, COMPOSITIONS AND METHODS FOR GENERATING THESE ORGANISMS
|
WO2008026198A2
(en)
|
2006-08-28 |
2008-03-06 |
Yeda Research And Development Co. Ltd. |
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
CN101595251B
(zh)
|
2006-10-05 |
2014-06-11 |
技术研究及发展基金有限公司 |
微管及其制备方法
|
US20080260678A1
(en)
*
|
2006-10-10 |
2008-10-23 |
University Of Colorado |
Molecular band-aid
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
JP5528807B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
JP2010507387A
(ja)
|
2006-10-25 |
2010-03-11 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
新規のsiRNAおよびその使用方法
|
CA2672756C
(en)
|
2006-12-20 |
2018-11-20 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
WO2008078091A1
(en)
|
2006-12-22 |
2008-07-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
MX2009006704A
(es)
|
2006-12-22 |
2009-06-30 |
Astex Therapeutics Ltd |
Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
|
WO2008087641A2
(en)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
WO2008093331A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Antibody conjugates for circumventing multi-drug resistance
|
EP2117616A2
(en)
|
2007-01-31 |
2009-11-18 |
Technion Research & Development Foundation Ltd. |
Electrospun scaffolds and methods of generating and using same
|
AU2008211549B2
(en)
|
2007-02-01 |
2012-12-06 |
Abraham Katzir |
Albumin fibers and fabrics and methods of generating and using same
|
US8748371B2
(en)
|
2007-02-28 |
2014-06-10 |
Yeda Research And Development Co. Ltd. |
Nuclear targeting sequences
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
EP2514766A3
(en)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
CN101854798B
(zh)
*
|
2007-04-09 |
2013-04-03 |
伊沃基因有限公司 |
用于增加植物的油含量、生长速率和/或产量的多核苷酸、多肽和方法
|
CA2684570A1
(en)
|
2007-04-19 |
2008-10-30 |
Molecular Detection Inc. |
Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
PT2144633E
(pt)
*
|
2007-04-23 |
2014-10-27 |
Deliversir Ltd |
Um sistema para a administração de agentes terapêuticos em células vivas e núcleos de células
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US8338113B2
(en)
|
2007-05-01 |
2012-12-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods for detecting fetal cells in the maternal blood
|
US10364413B2
(en)
|
2007-05-07 |
2019-07-30 |
Protalix Ltd. |
Large scale disposable bioreactor
|
PL2152663T3
(pl)
|
2007-06-04 |
2014-09-30 |
Ben Gurion Univ Of The Negev Research And Development Authority |
Związki triarylowe oraz kompozycje zawierające te związki
|
WO2009007980A1
(en)
|
2007-07-11 |
2009-01-15 |
Yeda Research And Development Co. Ltd. |
Nucleic acid construct systems capable of diagnosing or treating a cell state
|
CA2696833A1
(en)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
ES2685631T3
(es)
|
2007-07-24 |
2018-10-10 |
Evogene Ltd. |
Polinucleótidos, polipéptidos codificados por los mismos, y métodos de uso de los mismos para aumentar la tolerancia al estrés abiótico y/o biomasa y/o rendimiento en plantas que los expresan
|
EP2543389A3
(en)
|
2007-08-02 |
2013-04-24 |
Gilead Biologics, Inc. |
Methods and compositions inhibiting a lysyl oxidase (-like) protein for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
|
US20110052572A1
(en)
|
2007-08-15 |
2011-03-03 |
Yeda Research And Development Co. Ltd |
Regulators of mmp-9 and uses therof
|
JP5869219B2
(ja)
|
2007-08-16 |
2016-02-24 |
レメドー バイオメッド リミテッド |
治療および美容適用のためのエリスロポイエチンおよびフィブロネクチン組成物
|
AU2008299318A1
(en)
|
2007-09-12 |
2009-03-19 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods of treating tumors in immune-privileged sites
|
PT2200622E
(pt)
|
2007-09-19 |
2012-11-06 |
Pluristem Ltd |
Células aderentes provenientes de tecido adiposo ou placentário e respetiva utilização terapêutica
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
ES2505440T3
(es)
|
2007-10-19 |
2014-10-09 |
Rappaport Family Institute For Research In The Medical Sciences |
Composiciones que comprenden semaforinas para el tratamiento de las enfermedades relacionadas con la angiogénesis y los procedimientos de selección de las mismas
|
EP2220112B1
(en)
|
2007-11-26 |
2015-08-26 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions comprising fibrous polypeptides and polysaccharides
|
AU2008337286B2
(en)
*
|
2007-12-19 |
2014-08-07 |
Cancer Research Technology Limited |
Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
|
US20110119791A1
(en)
|
2007-12-27 |
2011-05-19 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
CN104491845A
(zh)
|
2008-04-18 |
2015-04-08 |
科尔普兰特有限公司 |
产生和使用原胶原的方法
|
EP2268129B1
(en)
|
2008-04-21 |
2015-06-17 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
GB0807609D0
(en)
*
|
2008-04-25 |
2008-06-04 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
MX367882B
(es)
*
|
2008-05-22 |
2019-09-10 |
Evogene Ltd |
Polinucleótidos y polipéptidos aislados y métodos para usarlos para incrementar el rendimiento de plantas, biomasa, velocidad de crecimiento, vigor, contenido de aceite, tolerancia al estrés abiótico de las plantas y eficiencia de uso de nitrógeno.
|
EP2641606A1
(en)
|
2008-05-27 |
2013-09-25 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
WO2009144718A1
(en)
|
2008-05-28 |
2009-12-03 |
Ramot At Tel Aviv University Ltd. |
Mesenchymal stem cells for the treatment of cns diseases
|
US8722348B2
(en)
*
|
2008-05-28 |
2014-05-13 |
Wayne State University |
Method and composition for a protein transduction technology and its applications
|
EP2293800B1
(en)
|
2008-06-06 |
2016-10-05 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treatment of ear disorders
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
EP2307542A1
(en)
*
|
2008-06-26 |
2011-04-13 |
Spectrum Health |
Method for treating or preventing radiation damage by in vivo gene therapy
|
EP2300607A2
(en)
|
2008-06-26 |
2011-03-30 |
Spectrum Health Innovations, LLC |
Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
|
EP2326419B1
(en)
|
2008-06-29 |
2021-04-07 |
Realbio Technologies Ltd. |
Liquid transfer device particularly useful as a capturing device in a biological assay process
|
EP2657342B1
(en)
|
2008-08-08 |
2015-11-18 |
Genisphere, LLC |
DNA dendrimers protected against nuclease degradation
|
EP4079146A3
(en)
*
|
2008-08-18 |
2023-01-25 |
Evogene Ltd. |
Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
|
PE20110419A1
(es)
|
2008-08-22 |
2011-07-13 |
Novartis Ag |
Compuestos de pirrolo-pirimidina como inhibidores de cdk
|
US8524496B2
(en)
|
2008-09-02 |
2013-09-03 |
Pluristem Ltd. |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
US20110305682A1
(en)
|
2008-09-11 |
2011-12-15 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and Methods for Treating S. Pneumonia Infection
|
WO2010031006A1
(en)
|
2008-09-12 |
2010-03-18 |
Cryopraxis Criobiologia Ltda. |
Ischemic tissue cell therapy
|
EP2789626B1
(en)
|
2008-09-24 |
2018-07-18 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
WO2010049897A2
(en)
|
2008-10-30 |
2010-05-06 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
US8734759B2
(en)
|
2008-12-05 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
MX340023B
(es)
|
2008-12-29 |
2016-06-22 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para aumentar la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan.
|
CA2748121C
(en)
|
2008-12-29 |
2017-12-12 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076788A2
(en)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
US8691760B2
(en)
|
2009-02-02 |
2014-04-08 |
Ramot At Tel-Aviv University |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
CN102439454B
(zh)
|
2009-02-11 |
2015-05-13 |
卡里斯Mpi公司 |
肿瘤的分子谱分析
|
EP2401362B1
(en)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
CA2753616C
(en)
|
2009-03-02 |
2018-07-17 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
WO2010103515A2
(en)
|
2009-03-09 |
2010-09-16 |
Ramot At Tel Aviv University Ltd. |
Compositions and methods for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
WO2010113096A1
(en)
|
2009-03-30 |
2010-10-07 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of predicting clinical course and treating multiple sclerosis
|
JP2012522762A
(ja)
|
2009-04-01 |
2012-09-27 |
ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター |
ケラチノサイトの増殖および分化を調節する方法
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
KR20180077322A
(ko)
|
2009-04-30 |
2018-07-06 |
텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. |
항-ceacam1 항체들과 이를 이용하는 방법들
|
US9182403B2
(en)
|
2009-05-19 |
2015-11-10 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
GB0908905D0
(en)
|
2009-05-26 |
2009-07-01 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2010137021A2
(en)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
US20120083477A1
(en)
|
2009-05-27 |
2012-04-05 |
Yeda Research And Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
JP2012529430A
(ja)
|
2009-06-08 |
2012-11-22 |
クォーク ファーマシューティカルズ インコーポレーティッド |
慢性腎臓疾患の治療方法
|
ES2773985T3
(es)
|
2009-06-10 |
2020-07-16 |
Evogene Ltd |
Polinucleótidos y polipéptidos aislados, y métodos para usar los mismos para incrementar la eficiencia en el uso de nitrógeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite, y/o tolerancia al estrés abiótico
|
EP2446267A1
(en)
|
2009-06-24 |
2012-05-02 |
Health Corporation - Rambam |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
ES2753986T3
(es)
|
2009-07-21 |
2020-04-15 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Un método de diagnóstico de cáncer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
US20120148546A1
(en)
|
2009-08-17 |
2012-06-14 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
CA2771774A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Gilead Biologics, Inc. |
In vitro screening assays
|
WO2011022670A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
In vivo screening assays
|
RU2012110587A
(ru)
*
|
2009-08-21 |
2013-09-27 |
Джилид Байолоджикс, Инк. |
Терапевтические способы и композиции
|
US20120157512A1
(en)
|
2009-08-21 |
2012-06-21 |
Monsanto Technology Llc |
Preventing and Curing Beneficial Insect Diseases Via Plant Transcribed Molecules
|
KR20120063488A
(ko)
|
2009-08-21 |
2012-06-15 |
길리아드 바이오로직스, 인크. |
리실 옥시다제 및 loxl2로부터의 촉매 도메인
|
RU2015124151A
(ru)
*
|
2009-08-21 |
2015-12-27 |
Джилид Байолоджикс, Инк. |
Способы и композиции для лечения фиброзных заболеваний легких
|
CN106619515A
(zh)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
EP2475381A2
(en)
|
2009-09-08 |
2012-07-18 |
Yeda Research and Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
EP2475784A1
(en)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
EP2478093A2
(en)
|
2009-09-17 |
2012-07-25 |
Yeda Research and Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
BR112012006005A2
(pt)
|
2009-09-17 |
2017-09-19 |
Univ Ramot |
"peptídeos no tratamento de transtorno associados ao estresse oxidativo"
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
CN102906263B
(zh)
|
2009-10-14 |
2017-05-31 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于控制蜂中的瓦螨的组合物
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
WO2011056688A2
(en)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Molecular profiling for personalized medicine
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
ES2932664T3
(es)
|
2009-11-12 |
2023-01-23 |
Technion Res & Dev Foundation |
Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
WO2011058557A1
(en)
|
2009-11-12 |
2011-05-19 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011061736A1
(en)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alkaline alpha galactosidase for the treatment of fabry disease
|
WO2011064773A1
(en)
|
2009-11-24 |
2011-06-03 |
Collplant Ltd. |
Method of generating collagen fibers
|
TW201124160A
(en)
|
2009-11-26 |
2011-07-16 |
Quark Pharmaceuticals Inc |
SiRNA compounds comprising terminal substitutions
|
EP2507362A2
(en)
|
2009-11-30 |
2012-10-10 |
Pluristem Ltd. |
Adherent cells from placenta and use of same in disease treatment
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
AR081095A1
(es)
|
2009-12-28 |
2012-06-13 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados y metodos para utilizarlos para aumentar el rendimiento de la planta, biomasa, tasa de crecimiento, vigor, contenido de aceite, tolerancia al estres abiotico y eficacia en el uso de nitrogeno
|
BR112012016203A2
(pt)
|
2009-12-29 |
2019-09-24 |
Gamida Cell Ltd |
"métodos para melhoria da proliferaçõ e atividade das células exterminadoras naturais"
|
AU2011204405B2
(en)
|
2010-01-05 |
2015-06-18 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
EP2523681A1
(en)
|
2010-01-12 |
2012-11-21 |
Vascular Biogenics Ltd. |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
EA201270701A1
(ru)
|
2010-01-27 |
2013-01-30 |
Йеда Рисеч Энд Девелопмент Ко. Лтд. |
Ингибирующие металлопротеины антитела
|
ES2469367T3
(es)
|
2010-02-01 |
2014-06-18 |
Cancer Research Technology Limited |
1-(5-Terc-butil-2-fenil-2H-pirazol-3-il)-3-[2-fluoro-4-(1-metil-2-oxo-2,3-dihidro-1H-imidazo[4,5-b]piridin-7-iloxi)-fenil]-urea y compuestos relacionados y su uso en terapia
|
AU2011212830B2
(en)
|
2010-02-04 |
2014-05-22 |
Gilead Biologics, Inc. |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2) and methods of use therefor
|
WO2011099006A2
(en)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
AU2011219426A1
(en)
|
2010-02-24 |
2012-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
PE20130649A1
(es)
|
2010-03-08 |
2013-07-13 |
Monsanto Technology Llc |
Moleculas polinucleotidicas para regulacion genetica en plantas
|
WO2011111050A2
(en)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Methods of generating hydrogen
|
US9073990B2
(en)
|
2010-04-05 |
2015-07-07 |
Bar-Llan University |
Protease-activatable pore-forming polypeptides
|
US9458438B2
(en)
|
2010-04-12 |
2016-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
IN2012MN02247A
(da)
|
2010-04-18 |
2015-06-12 |
Yeda Res & Dev |
|
BR122021002337B1
(pt)
|
2010-04-28 |
2022-03-22 |
Evogene Ltd |
Método de aumento de produção, biomassa, taxa de crescimento, vigor, teor de óleo, produção de fibra qualidade de fibra, tolerância ao estresse abiótico e/ou eficiência de uso de nitrogênio de uma planta, e construto de ácido nucleico isolado
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
WO2011138778A2
(en)
|
2010-05-04 |
2011-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
EP2566500B1
(en)
|
2010-05-05 |
2017-04-12 |
Rappaport Family Institute for Research in the Medical Sciences |
Ccl1 for use in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
ES2672918T3
(es)
|
2010-05-13 |
2018-06-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Poblaciones aisladas de células renales adultas y métodos para aislar y usar las mismas
|
CN103037891A
(zh)
|
2010-06-03 |
2013-04-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗糖尿病的方法和能够治疗糖尿病的组合物
|
WO2011154940A1
(en)
|
2010-06-07 |
2011-12-15 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
WO2011158242A2
(en)
|
2010-06-16 |
2011-12-22 |
Futuragene Israel Ltd. |
Pest -resistant plants containing a combination of a spider toxin and a chitinase
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
NZ604094A
(en)
|
2010-06-24 |
2014-11-28 |
Quark Pharmaceuticals Inc |
Double stranded rna compounds to rhoa and use thereof
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
CN103108955B
(zh)
|
2010-07-15 |
2015-11-25 |
工业研究与发展基金会有限公司 |
用于提高植物中非生物胁迫耐受性的核酸构建体
|
EP2593480A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
WO2012007951A1
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
|
WO2012011113A2
(en)
|
2010-07-22 |
2012-01-26 |
Shai Yarkoni |
Regulatory immune cells with enhanced targeted cell death effect
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
EP2600885A2
(en)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
SG187830A1
(en)
|
2010-08-22 |
2013-03-28 |
Univ Ramot |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
US10457954B2
(en)
|
2010-08-30 |
2019-10-29 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
SG10202109393RA
(en)
|
2010-09-07 |
2021-10-28 |
Technion Res & Dev Foundation |
Novel Methods And Culture Media For Culturing Pluripotent Stem Cells
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
US20130164288A1
(en)
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
CN103270050A
(zh)
|
2010-09-08 |
2013-08-28 |
耶达研究及发展有限公司 |
用于稳定和长期移植的免疫抑制药物组合
|
JP5977238B2
(ja)
|
2010-09-08 |
2016-08-24 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
抗白血病/リンパ腫処置のための抗第三者セントラルメモリーt細胞の使用
|
CN103210082A
(zh)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
扩增胰岛β细胞和使其再分化的方法
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
EP2627766B1
(en)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
US20130227724A1
(en)
|
2010-11-03 |
2013-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
CA2817830A1
(en)
|
2010-11-15 |
2012-05-24 |
Ramot At Tel Aviv University Ltd. |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
JP6139410B2
(ja)
|
2010-12-02 |
2017-05-31 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
角膜細胞の作製方法および該角膜細胞を含む細胞集団
|
SG190412A1
(en)
|
2010-12-06 |
2013-06-28 |
Quark Pharmaceuticals Inc |
Double stranded oligonucleotide compounds comprising threose modifications
|
EP2463382A1
(en)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Method for identifying E. Coli M-17
|
AU2011338210B2
(en)
|
2010-12-09 |
2016-05-12 |
Orig3N, Inc. |
Improved method and kit for determining severity and progression of periodontal disease
|
US9404087B2
(en)
|
2010-12-15 |
2016-08-02 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
JP2014501748A
(ja)
|
2010-12-21 |
2014-01-23 |
リコファーマ アーベー |
涙代用物
|
AR084511A1
(es)
|
2010-12-22 |
2013-05-22 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la tolerancia al estres abiotico, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o eficacia en el uso de nitrogeno de las plantas
|
CN103533947A
(zh)
|
2010-12-28 |
2014-01-22 |
卡梅迪斯有限公司 |
用于治疗和预防感染的植物提取物
|
PL3272861T3
(pl)
|
2011-01-20 |
2020-07-13 |
Protalix Ltd. |
Kompozycje alfa- galaktozydazy
|
WO2012104851A1
(en)
|
2011-01-31 |
2012-08-09 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
BR112013022331B1
(pt)
|
2011-03-02 |
2021-01-26 |
Futuragene Israel Ltd. |
vetor de expressão de ácido nucleico, e, método para gerar uma planta que compreende resistência intensificada a um patógeno bacteriano
|
SG193280A1
(en)
|
2011-03-03 |
2013-10-30 |
Quark Pharmaceuticals Inc |
Oligonucleotide modulators of the toll-like receptor pathway
|
WO2012117373A1
(en)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
US9796979B2
(en)
|
2011-03-03 |
2017-10-24 |
Quark Pharmaceuticals Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
CA2829110C
(en)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
WO2012120518A1
(en)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (pku)
|
IN2013MN01438A
(da)
|
2011-03-17 |
2015-06-12 |
Univ Ramot |
|
CN103533934B
(zh)
|
2011-03-17 |
2016-03-30 |
特尔汗什莫尔医学基础设施研究和服务公司 |
用于治疗自身免疫性疾病的喹诺酮类似物
|
WO2012127320A1
(en)
|
2011-03-22 |
2012-09-27 |
Pluristem Ltd. |
Methods for treating radiation or chemical injury
|
US20140045764A1
(en)
|
2011-03-24 |
2014-02-13 |
Neurim Pharmaceuticals (1991) Ltd. |
Neuroprotective peptides
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
DK2694962T3
(da)
|
2011-04-06 |
2017-06-12 |
Ramot At Tel-Aviv Univ Ltd |
Fremgangsmåder til monitorering og analyse af profiler for metabolisk aktivitet samt diagnostiske og terapeutiske anvendelser deraf
|
AU2012241521B2
(en)
|
2011-04-15 |
2016-07-14 |
Pluri Biotech Ltd |
Methods and systems for harvesting cells
|
GB201106817D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compound
|
GB201106814D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compounds
|
PT2705143T
(pt)
|
2011-05-02 |
2021-04-07 |
Univ Wayne State |
Tecnologia de células pluripotentes induzidas por proteínas e utilizações da mesma
|
AR086243A1
(es)
|
2011-05-03 |
2013-11-27 |
Evogene Ltd |
Polipeptidos y polinucleotidos aislados y metodos para su uso, para aumentar el rendimiento, la biomasa, el indice de crecimiento, el vigor, el contenido de aceite, la tolerancia al estres abiotico de las plantas y la eficiencia en el uso del nitrogeno
|
WO2012150600A2
(en)
|
2011-05-04 |
2012-11-08 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
EP3263127B1
(en)
|
2011-05-23 |
2019-08-21 |
Yeda Research and Development Co. Ltd |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
CN107325164A
(zh)
|
2011-05-31 |
2017-11-07 |
和黄生物膜医疗解决方案有限公司 |
细胞聚集体的分散和脱离
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP2720720B1
(en)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Combination therapy to prevent dcis formation and progression to breast cancer
|
US20140130199A1
(en)
|
2011-06-23 |
2014-05-08 |
Kaiima Bio Agritech Ltd. |
Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
|
RU2014106125A
(ru)
|
2011-07-20 |
2015-08-27 |
Каиима Био Агритех Лтд. |
Растения кукурузы с частично или полностью умноженным геномом и их применения
|
EP2550982A1
(en)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Devices for surgical applications
|
HUE044154T2
(hu)
|
2011-08-04 |
2019-09-30 |
Yeda Res & Dev |
MIR-15 mikro-RNS, valamint az ezt tartalmazó készítmények kortikotropin-felszabadító hormonhoz kapcsolódó orvosi állapotok kezelésére
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
US20140212568A1
(en)
|
2011-08-14 |
2014-07-31 |
Kaiimam Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
EP2753367A4
(en)
|
2011-09-07 |
2015-10-14 |
Yeda Res & Dev |
OLFACTORY SIGNATURE AND ODORING MIXTURE THEREWITH
|
ES2657552T3
(es)
|
2011-09-08 |
2018-03-05 |
Yeda Research And Development Co. Ltd. |
Nuevos biomarcadores de riesgo para el cáncer de pulmón
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
CA2848695A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and composition for weed control comprising inhibiting ppg oxidase
|
WO2013040057A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013040033A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CN107739737A
(zh)
|
2011-09-13 |
2018-02-27 |
孟山都技术公司 |
用于杂草控制的方法和组合物
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
WO2013061328A2
(en)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Method of treating cancer
|
GB201118652D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
US9422560B2
(en)
|
2011-11-03 |
2016-08-23 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for neuroprotection
|
EP2776565A1
(en)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
CN104105493A
(zh)
|
2011-12-08 |
2014-10-15 |
耶达研究及发展有限公司 |
哺乳动物胎儿肺细胞以及其治疗用途
|
UA116097C2
(uk)
|
2011-12-11 |
2018-02-12 |
Зе Стейт Оф Ізраел, Міністрі Оф Агрікалче Енд Руерал Девелопмент, Агрікалчерал Рісьоч Організейшн, (А.Р.О.), Волкані Сентре |
Спосіб модуляції провідності устячка рослини
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
US10434121B2
(en)
|
2011-12-22 |
2019-10-08 |
Yeda Research And Development Co. Ltd. |
Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
|
CN105833925B
(zh)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
WO2013098820A1
(en)
|
2011-12-28 |
2013-07-04 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
US20150216998A1
(en)
|
2012-01-01 |
2015-08-06 |
Ramot At Tel-Aviv University Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
KR20140111673A
(ko)
|
2012-01-12 |
2014-09-19 |
쿠아크 파마수티칼스 인코퍼레이티드 |
청력 및 균형 장애를 치료하기 위한 조합요법
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
WO2013114371A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dry powder formulations of dnase i
|
GB201202027D0
(en)
|
2012-02-06 |
2012-03-21 |
Sareum Ltd |
Pharmaceutical compounds
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
CA2863795A1
(en)
|
2012-02-13 |
2013-08-22 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
SG11201404836QA
(en)
|
2012-02-14 |
2014-12-30 |
Opko Biolog Ltd |
Long-acting coagulation factors and methods of producing same
|
WO2013121405A1
(en)
|
2012-02-19 |
2013-08-22 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
EP2844744A2
(en)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
MicroRNAS FOR THE GENERATION OF ASTROCYTES
|
EP3401394A1
(en)
|
2012-02-22 |
2018-11-14 |
Exostem Biotec Ltd |
Generation of neural stem cells
|
WO2013128454A1
(en)
|
2012-03-01 |
2013-09-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
CA2865486C
(en)
|
2012-03-07 |
2021-03-30 |
Yeda Research And Development Co. Ltd. |
Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same
|
EP2828280B1
(en)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Plif multimeric peptides and uses thereof
|
IN2014MN01886A
(da)
|
2012-04-18 |
2015-07-10 |
Univ Ramot |
|
WO2013157002A1
(en)
|
2012-04-19 |
2013-10-24 |
Prolor Biotech Inc. |
Long-acting oxyntomodulin variants and methods of producing same
|
WO2013160895A1
(en)
|
2012-04-24 |
2013-10-31 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
CA2873828A1
(en)
|
2012-05-24 |
2013-11-28 |
A.B. Seeds Ltd. |
Naked dsrna for silencing target molecules in plant seeds
|
WO2013173923A1
(en)
|
2012-05-25 |
2013-11-28 |
Diamedica, Inc. |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
GB201209609D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
EP2855507B1
(en)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
SG11201408054RA
(en)
|
2012-06-04 |
2015-01-29 |
Opko Biolog Ltd |
Pegylated oxm variants
|
DK2854841T3
(da)
|
2012-06-04 |
2017-05-22 |
Diamedica Inc |
Kallikrein-1-glycosyleringsisoformer af humant væv
|
EP2870110A1
(en)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
CA2879443A1
(en)
|
2012-07-19 |
2014-01-23 |
Zoetis Llc |
Bovine influenza virus compositions
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
WO2014018724A1
(en)
|
2012-07-27 |
2014-01-30 |
Zoetis Llc |
Tick toxin compositions
|
EP3594331A1
(en)
|
2012-07-29 |
2020-01-15 |
Yeda Research and Development Co. Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
CN104684558A
(zh)
|
2012-07-31 |
2015-06-03 |
耶达研究及发展有限公司 |
诊断和治疗运动神经元疾病的方法
|
JP6362596B2
(ja)
|
2012-08-06 |
2018-07-25 |
ブレインストーム セル セラペウティクス リミテッド |
神経栄養因子を分泌する間葉系幹細胞の作製方法
|
US20140068814A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
US9932578B2
(en)
|
2012-09-12 |
2018-04-03 |
Quark Pharmaceuticals, Inc. |
Double-stranded oligonucleotide molecules to P53 and methods of use thereof
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
EP2895608B1
(en)
|
2012-09-12 |
2018-12-05 |
Quark Pharmaceuticals, Inc. |
Double-stranded oligonucleotide molecules to p53 and methods of use thereof
|
WO2014057490A1
(en)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
EP2912182B1
(en)
|
2012-10-23 |
2021-12-08 |
Caris Science, Inc. |
Aptamers and uses thereof
|
EP3584259A1
(en)
|
2012-10-24 |
2019-12-25 |
Yeda Research and Development Co., Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
WO2014068553A1
(en)
|
2012-10-29 |
2014-05-08 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
EP2922867B1
(en)
|
2012-11-20 |
2021-07-21 |
OPKO Biologics Ltd. |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
IN2014MN02655A
(da)
|
2012-11-29 |
2015-08-21 |
Yeda Res & Dev |
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
AU2013361323B2
(en)
|
2012-12-19 |
2018-09-06 |
Caris Science, Inc. |
Compositions and methods for aptamer screening
|
EA032406B1
(ru)
|
2013-01-01 |
2019-05-31 |
Эй.Би. СИДЗ ЛТД. |
СПОСОБЫ ВВЕДЕНИЯ дсРНК В СЕМЕНА РАСТЕНИЙ ДЛЯ МОДУЛЯЦИИ ЭКСПРЕССИИ ГЕНОВ
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014111936A1
(en)
|
2013-01-17 |
2014-07-24 |
Novellusdx Ltd. |
Methods and systems for identifying patient specific driver mutations
|
EP2950808B1
(en)
|
2013-02-04 |
2019-08-21 |
Ramot at Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
JP2016511768A
(ja)
|
2013-02-22 |
2016-04-21 |
ゾエティス・サービシーズ・エルエルシー |
家禽類の成績を改善するための成長因子の卵内投与
|
WO2014136114A1
(en)
|
2013-03-06 |
2014-09-12 |
Protalix Ltd. |
TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
|
US10087232B2
(en)
|
2013-03-06 |
2018-10-02 |
Protalix Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
WO2014135984A2
(en)
|
2013-03-07 |
2014-09-12 |
Recopharma Ab |
Glycosylated mucin-immunoglobulin fusion protein coated device
|
AR095232A1
(es)
|
2013-03-13 |
2015-09-30 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas
|
UY35385A
(es)
|
2013-03-13 |
2014-09-30 |
Monsanto Technology Llc |
?métodos y composiciones para el control de malezas?.
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10493134B2
(en)
|
2013-03-21 |
2019-12-03 |
Collplant Ltd. |
Compositions comprising collagen and PRP for tissue regeneration
|
CA2906314A1
(en)
|
2013-03-24 |
2014-10-02 |
Biolinerx Ltd. |
Methods of treating myeloid leukemia
|
EP2986627B1
(en)
|
2013-04-18 |
2019-04-10 |
Carmel Haifa University Economic Corporation Ltd. |
Inhibitors of the eph-a receptor and uses thereof
|
RU2015149680A
(ru)
|
2013-04-21 |
2017-05-24 |
Йеда Ресеарч Энд Девелопмент Ко. Лтд. |
Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
|
WO2014174470A1
(en)
|
2013-04-23 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Isolated naive pluripotent stem cells and methods of generating same
|
US9714268B2
(en)
|
2013-04-25 |
2017-07-25 |
Yeda Research And Development Co. Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
GB201307577D0
(en)
|
2013-04-26 |
2013-06-12 |
Astex Therapeutics Ltd |
New compounds
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
EP3626310A1
(en)
|
2013-05-27 |
2020-03-25 |
Rakuto Bio Technologies Ltd. |
Enzymatic system containing cosmetic compositions
|
WO2014207744A1
(en)
|
2013-06-24 |
2014-12-31 |
Ramot At Tel-Aviv University Ltd. |
Omentum based scaffold and delivery system
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
BR112016000555B1
(pt)
|
2013-07-19 |
2022-12-27 |
Monsanto Technology Llc |
Método para controlar uma infestação da espécie de leptinotarsa em uma planta, composição inseticida e construção de dna recombinante
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
WO2015015496A1
(en)
|
2013-07-31 |
2015-02-05 |
Qbi Enterprises Ltd. |
Sphingolipid-polyalkylamine-oligonucleotide compounds
|
EP3027223A1
(en)
|
2013-07-31 |
2016-06-08 |
QBI Enterprises Ltd. |
Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
|
IL228026B
(en)
|
2013-08-19 |
2018-05-31 |
Technion Res & Dev Foundation |
Discovery of genetic sequences using pna sensors and isotachophoresis
|
CN105980615A
(zh)
|
2013-08-28 |
2016-09-28 |
卡里斯生命科学瑞士控股有限公司 |
寡核苷酸探针及其用途
|
CN105849117B
(zh)
|
2013-08-29 |
2017-12-12 |
耶达研究及发展有限公司 |
Na,K‑ATP酶的α2亚型的选择性抑制剂和用于降低眼内压的用途
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033343A1
(en)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
US9695402B2
(en)
|
2013-09-17 |
2017-07-04 |
Yeda Research And Development Co. Ltd. |
ERK-derived peptides and uses thereof
|
WO2015049677A1
(en)
|
2013-10-01 |
2015-04-09 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
|
TW201536312A
(zh)
|
2013-10-21 |
2015-10-01 |
Opko Biolog Ltd |
長效型多肽及其生產和給藥的方法
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
WO2015059690A1
(en)
|
2013-10-24 |
2015-04-30 |
Yeda Research And Development Co. Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using s ame
|
DK3060237T3
(da)
|
2013-10-25 |
2021-10-25 |
Univ Wayne State |
Modificeret omprogrammeringsprotein til anvendelse i behandling af cancer
|
EP3062809B1
(en)
|
2013-10-31 |
2020-07-08 |
Biokine Therapeutics Ltd. |
A cxcr4 peptide inhibitor for use in treating acute myeloid leukemia with a flt3 mutation
|
AR098295A1
(es)
|
2013-11-04 |
2016-05-26 |
Monsanto Technology Llc |
Composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos
|
EP3068783B1
(en)
|
2013-11-15 |
2020-09-23 |
The Board of Trustees of the Leland Stanford Junior University |
Agonists of hypocretin receptor 2 for use for treating heart failure
|
GB201320732D0
(en)
|
2013-11-25 |
2014-01-08 |
Cancer Rec Tech Ltd |
Methods of chemical synthesis
|
GB201320729D0
(en)
|
2013-11-25 |
2014-01-08 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
EP3074391B1
(en)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
WO2015079446A1
(en)
|
2013-11-29 |
2015-06-04 |
Technion Research & Development Foundation Limited |
Metod and device for accelerated surface-based reactions
|
EP2878681B1
(en)
|
2013-11-29 |
2020-03-04 |
Technion Research And Development Foundation, Ltd. |
Continuous cell detection by isotachophoresis
|
DK3080243T3
(da)
|
2013-12-10 |
2019-01-07 |
Yeda Res & Dev |
Anvendelse af enzymer, som katalyserer pyruvatsyntese ud fra formiat og acetyl-coa, samt bakterier, der udtrykker dette
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
CN105829310B
(zh)
|
2013-12-20 |
2019-04-12 |
阿斯特克斯治疗有限公司 |
双环杂环化合物及其治疗用途
|
MX368629B
(es)
|
2014-01-15 |
2019-10-08 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas utilizando polinucleotidos de 5-enolpiruvilshikimato-3-fosfato sintasa (epsps).
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
WO2015114638A2
(en)
|
2014-02-03 |
2015-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of eliminating stem cells
|
CN106715695B
(zh)
|
2014-02-05 |
2020-07-31 |
耶达研究及发展有限公司 |
用于治疗和诊断的微rna和包含所述微rna的组合物
|
US10066014B2
(en)
|
2014-02-06 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Anti CD84 antibodies, compositions comprising same and uses thereof
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
JP6628253B2
(ja)
|
2014-02-11 |
2020-01-08 |
ブレインストーム セル セラペウティクス リミテッド |
細胞の適性を判定する方法
|
CN106255882A
(zh)
|
2014-03-03 |
2016-12-21 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于检测铜绿假单胞菌的方法和装置
|
HUE053653T2
(hu)
|
2014-03-26 |
2021-07-28 |
Astex Therapeutics Ltd |
FGFR inhibitor és IGF1R inhibitor kombinációi
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
WO2015144804A1
(en)
|
2014-03-26 |
2015-10-01 |
Astex Therapeutics Ltd |
Combinations
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
BR112016022711A2
(pt)
|
2014-04-01 |
2017-10-31 |
Monsanto Technology Llc |
composições e métodos para controle de pragas de inseto
|
CA2945438C
(en)
|
2014-04-10 |
2023-08-22 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
FI4026917T3
(fi)
|
2014-04-14 |
2024-02-14 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
Menetelmä ja välineistö solujen tai kudoksen kuoleman tai DNA:n kudos- tai solualkuperäin määrittämiseksi DNA-metylaatioanalyysin avulla
|
US10590467B2
(en)
|
2014-04-17 |
2020-03-17 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing DNA binding moieties attached to DNA
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
EP3137502B1
(en)
|
2014-04-27 |
2020-07-29 |
FameWave Ltd. |
Humanized antibodies against ceacam1
|
WO2015166492A2
(en)
|
2014-04-28 |
2015-11-05 |
Yeda Research And Development Co. Ltd. |
Microbiome response to agents
|
EP3140401A2
(en)
|
2014-05-04 |
2017-03-15 |
Forrest Innovations Ltd. |
Compositions for mosquito control and uses of same
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186128A1
(en)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
AU2015280252A1
(en)
|
2014-06-23 |
2017-01-12 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via RNA interference
|
US20170183376A1
(en)
|
2014-06-24 |
2017-06-29 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
ES2791199T3
(es)
|
2014-06-25 |
2020-11-03 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Identificación de marcadores de células madre cancerosas y uso de los mismos para diagnóstico y tratamiento
|
WO2015200539A1
(en)
|
2014-06-25 |
2015-12-30 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
WO2015198326A1
(en)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
EP3169343B1
(en)
|
2014-07-15 |
2020-03-25 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Isolated polypeptides of cd44 and uses thereof
|
CN106715719B
(zh)
|
2014-07-21 |
2022-08-02 |
福尔生物治疗有限公司 |
用于确定患者特定突变的药物反应的方法
|
WO2016013008A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
US10378012B2
(en)
|
2014-07-29 |
2019-08-13 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
WO2016016894A1
(en)
|
2014-07-30 |
2016-02-04 |
Yeda Research And Development Co. Ltd. |
Media for culturing pluripotent stem cells
|
CN111624346A
(zh)
|
2014-08-14 |
2020-09-04 |
米密德诊断学有限公司 |
用于预测及/或决定预后的套组
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
CA2959716A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
WO2016038610A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
WO2016042561A2
(en)
|
2014-09-21 |
2016-03-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating mir-132 for the treatment of lipid related disorders
|
US10570368B2
(en)
|
2014-11-13 |
2020-02-25 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
EP3220945A2
(en)
|
2014-11-17 |
2017-09-27 |
Yeda Research and Development Co., Ltd. |
Methods of treating diseases related to mitochondrial function
|
CA2967233A1
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Method of analyzing microbiome
|
EA038931B9
(ru)
|
2014-11-20 |
2022-02-18 |
Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. |
Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
|
JP6860483B2
(ja)
|
2014-11-26 |
2021-04-14 |
テクノロジー イノベーション モメンタム ファンド(イスラエル)リミテッド パートナーシップTechnology Innovation Momentum Fund(israel)Limited Partnership |
細菌遺伝子の標的化削減
|
EP3224363B1
(en)
|
2014-11-27 |
2021-11-03 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Nucleic acid constructs for genome editing
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
EP3233099A1
(en)
|
2014-12-17 |
2017-10-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Phage therapy for targeting enterococci
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
BR112017014345A2
(pt)
|
2014-12-30 |
2018-01-02 |
Cell Cure Neurosciences Ltd. |
populações de células do rpe e métodos de gerar as mesmas
|
AU2015373051B2
(en)
|
2014-12-30 |
2022-10-06 |
Cell Cure Neurosciences Ltd. |
Assessing retinal pigment epithelial cell populations
|
RU2017125957A
(ru)
|
2015-01-04 |
2019-02-04 |
Проталикс Лтд. |
Модифицированная днказа и ее применения
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
PL3256589T3
(pl)
|
2015-01-22 |
2022-02-21 |
Monsanto Technology Llc |
Kompozycje i sposoby kontrolowania leptinotarsa
|
JOP20200201A1
(ar)
|
2015-02-10 |
2017-06-16 |
Astex Therapeutics Ltd |
تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
|
WO2016135733A1
(en)
|
2015-02-26 |
2016-09-01 |
Urifer Ltd. |
Modulators of cell death processes
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
WO2016145128A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
US10781445B2
(en)
|
2015-03-11 |
2020-09-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
AU2016228514B2
(en)
|
2015-03-12 |
2021-06-17 |
Zoetis Services Llc |
Pyolysin methods and compositions
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
EP4218771A1
(en)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods of treating motor neuron diseases
|
JP2018511325A
(ja)
|
2015-03-31 |
2018-04-26 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
グルタミン酸オキサロ酢酸トランスアミナーゼ1(got1)、その調製物および製造方法およびその使用
|
US10960035B2
(en)
|
2015-04-01 |
2021-03-30 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
US10478494B2
(en)
|
2015-04-03 |
2019-11-19 |
Astex Therapeutics Ltd |
FGFR/PD-1 combination therapy for the treatment of cancer
|
HUE057044T2
(hu)
|
2015-04-07 |
2022-04-28 |
Ela Pharma Ltd |
Sejt- vagy szövetnekrózis kezelésére és/vagy megelõzésére szolgáló, katepszin C-t és/vagy CELA1-et és/vagy CELA3A-t és/vagy szerkezetileg rokon enzimeket specifikusan targetáló készítmények
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
IL255290B2
(en)
|
2015-04-27 |
2024-01-01 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Substances that bind to EGF1 and their use in the treatment of inflammatory diseases and tumors
|
ES2911341T3
(es)
|
2015-04-29 |
2022-05-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Composiciones antifitopatogénicas
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
EP3292219B9
(en)
|
2015-05-04 |
2022-05-18 |
Ramot at Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
EP3294280A1
(en)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
CN107847531A
(zh)
|
2015-05-21 |
2018-03-27 |
耶达研究及发展有限公司 |
用于促进健康的细菌群
|
AU2016273045B2
(en)
|
2015-05-29 |
2020-11-26 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
US10883103B2
(en)
|
2015-06-02 |
2021-01-05 |
Monsanto Technology Llc |
Compositions and methods for delivery of a polynucleotide into a plant
|
CN108024517A
(zh)
|
2015-06-03 |
2018-05-11 |
孟山都技术公司 |
用于将核酸引入到植物中的方法和组合物
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
US10668109B2
(en)
|
2015-06-18 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Conditioning protocols and use of same for tissue regeneration
|
PL3310347T3
(pl)
|
2015-06-19 |
2021-12-27 |
Opko Biologics Ltd. |
Długo działające czynniki krzepnięcia i sposoby wytwarzania
|
US10590425B2
(en)
|
2015-06-29 |
2020-03-17 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
US10682390B2
(en)
|
2015-07-16 |
2020-06-16 |
Biokine Therapeutics Ltd. |
Compositions and methods for treating cancer
|
DK3322425T3
(da)
|
2015-07-16 |
2023-06-12 |
Yeda Res & Dev |
Genmodificerede anti-tredjeparts-centralhukommelse-t-celler og brug af samme i immunterapi
|
WO2017013648A1
(en)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE
|
BR112018001310A2
(pt)
|
2015-07-22 |
2018-09-11 |
Phytopharma Int Ltd |
composições ingeríveis por abelha, métodos de uso das mesmas para a produção de mel e mel produzido por estas
|
AU2016298317B2
(en)
|
2015-07-28 |
2021-02-18 |
Caris Science, Inc. |
Targeted oligonucleotides
|
EP3328995B1
(en)
|
2015-07-29 |
2021-03-31 |
Hadasit Medical Research Services And Development |
Large scale production of retinal pigment epithelial cells
|
EP3331546B1
(en)
|
2015-08-03 |
2023-10-04 |
Biokine Therapeutics Ltd. |
Cxcr4 inhibitor for the treatment of cancer
|
WO2017021961A1
(en)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
CN108138144A
(zh)
|
2015-08-05 |
2018-06-08 |
细胞治疗神经科学有限公司 |
视网膜色素上皮细胞的制备
|
AU2016303631B2
(en)
|
2015-08-05 |
2022-07-28 |
Cell Cure Neurosciences Ltd. |
Preparation of photoreceptors for the treatment of retinal diseases
|
US10639350B2
(en)
|
2015-08-10 |
2020-05-05 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using CD24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
CN115141772A
(zh)
|
2015-08-14 |
2022-10-04 |
硕腾服务有限责任公司 |
牛支原体组合物
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042814A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Use of perforin positive immature dendritic cells in disease treatment
|
JP6898919B2
(ja)
|
2015-09-23 |
2021-07-07 |
ヤンセン ファーマシューティカ エヌ.ベー. |
新規化合物
|
LT3353164T
(lt)
|
2015-09-23 |
2022-01-25 |
Janssen Pharmaceutica, N.V. |
Diheteroarilpakeistieji 1,4-benzodiazepinai ir jų naudojimas vėžio gydymui
|
GB201517217D0
(en)
|
2015-09-29 |
2015-11-11 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
MX2018003887A
(es)
|
2015-10-02 |
2019-04-01 |
Sentinel Oncology Ltd |
Derivados de 2-aminoquinazolina como inhibidores de cinasa p70s6.
|
EP3365376A1
(en)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
US20180312805A1
(en)
|
2015-10-26 |
2018-11-01 |
Cell Cure Neurosciences Ltd. |
Preparation of Retinal Pigment Epithelium Cells
|
CA3002767C
(en)
|
2015-10-27 |
2023-03-14 |
Zvi VOGEL |
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
WO2017081689A1
(en)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
BR112018010946A2
(pt)
|
2015-11-30 |
2018-12-04 |
Kadimastem Ltd |
método para enriquecimento de células endócrinas pancreáticas, população enriquecida de células endócrinas pancreáticas, método de tratamento de diabetes e método de preparação de células beta de produção de insulina
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
EP4059507B1
(en)
|
2015-12-16 |
2024-06-05 |
Ramot at Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
IL260331B2
(en)
|
2015-12-28 |
2024-10-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Compounds and methods for the treatment of amyotrophic lateral sclerosis
|
US10828318B2
(en)
|
2016-01-06 |
2020-11-10 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
WO2017122203A1
(en)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
CN109068605B
(zh)
|
2016-01-21 |
2022-11-11 |
以色列国家农业和农村发展农业研究组织沃尔坎尼中心 |
单性结实植物及其产生方法
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
EP3408376A1
(en)
|
2016-01-31 |
2018-12-05 |
Hadasit Medical Research Services and Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
WO2017134671A1
(en)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
WO2017138007A1
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
AU2017220830A1
(en)
|
2016-02-16 |
2018-09-06 |
Yeda Research And Development Co. Ltd. |
Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
|
EP3420075A4
(en)
|
2016-02-23 |
2019-10-16 |
Chaya Brodie |
PRODUCTION OF CANCER STEM CELLS AND USE THEREOF
|
KR20180133399A
(ko)
|
2016-03-01 |
2018-12-14 |
이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
인간 폴리오바이러스 수용체(pvr)에 특이적인 항체
|
CN114959084A
(zh)
|
2016-03-03 |
2022-08-30 |
米密德诊断学有限公司 |
分析rna用于诊断感染类型
|
WO2017153982A1
(en)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
KR20190008843A
(ko)
|
2016-03-18 |
2019-01-25 |
카리스 싸이언스, 인코포레이티드 |
올리고뉴클레오티드 프로브 및 이의 용도
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
EP3463402B1
(en)
|
2016-05-22 |
2021-06-23 |
Yeda Research and Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
EP3464630A1
(en)
|
2016-05-23 |
2019-04-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
WO2017205686A1
(en)
|
2016-05-25 |
2017-11-30 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
WO2017212476A1
(en)
|
2016-06-05 |
2017-12-14 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Novel molecules for the treatment of inflammation
|
EP3468610A1
(en)
|
2016-06-09 |
2019-04-17 |
OPKO Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(en)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
IL246378A0
(en)
|
2016-06-21 |
2016-11-30 |
Technion Res & Dev Foundation |
A hybrid matrix of polymers that adhere to the mucosa and a lipidic drug release system for the treatment of oral cancer
|
JP7334043B2
(ja)
|
2016-06-27 |
2023-08-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
メモリーt細胞から作られるベト細胞
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
EP4141448A1
(en)
|
2016-07-10 |
2023-03-01 |
MeMed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
CA3030533A1
(en)
|
2016-07-11 |
2018-01-18 |
Oren HERSHKOVITZ |
Long-acting coagulation factor vii and methods of producing same
|
JP7268943B2
(ja)
|
2016-07-11 |
2023-05-08 |
ボーナス セラピューティックス リミテッド |
組織再生のための細胞組成物
|
US20200080050A1
(en)
|
2016-07-11 |
2020-03-12 |
Yaakov Nahmias |
Systems and methods for growing cells in vitro
|
EP3481412A4
(en)
|
2016-07-11 |
2020-03-18 |
The National Institute for Biotechnology in the Negev, Ltd. |
FUSION PROTEINS WITH EXTENDED SERUM HALF-VALUE
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
EP3484517A4
(en)
|
2016-07-18 |
2020-04-15 |
Ramot at Tel-Aviv University Ltd. |
MODULAR PLATFORM FOR TARGETED THERAPEUTICS
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP4033248B1
(en)
|
2016-08-10 |
2024-04-10 |
MeMed Diagnostics Ltd. |
System and method for analysis of mx1 and crp in blood
|
EP3497239A4
(en)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
METHYLATION STATUS ANALYSIS AND COPY NUMBER
|
IL264825B
(en)
|
2016-08-14 |
2022-08-01 |
Univ Ramot |
Exosomes from mesenchymal cells for the treatment of neurological diseases
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
US11612607B2
(en)
*
|
2016-08-31 |
2023-03-28 |
Taro Pharmaceuticals Industries Ltd. |
Fenoldopam topical formulations for treating skin disorders
|
WO2018047154A1
(en)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
EP3512943B1
(en)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
|
WO2018051355A1
(en)
|
2016-09-19 |
2018-03-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Tamoxifen or tamoxifen in combination with arginine/citrulline for the use in the treatment of muscular dystrophy
|
WO2018060998A1
(en)
|
2016-09-29 |
2018-04-05 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
US11119068B2
(en)
|
2016-10-06 |
2021-09-14 |
Technion Research & Development Foundation Limited |
Device and method for isotachophoretic focusing large sample volumes
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
AU2017368911B2
(en)
|
2016-12-01 |
2022-03-10 |
Ramot At Tel-Aviv University Ltd. |
Combined treatment for nerve injuries
|
EP3555128B1
(en)
|
2016-12-15 |
2023-12-27 |
The National Institute for Biotechnology in the Negev Ltd. |
Anti-pcna monoclonal antibodies and use thereof
|
US11555178B2
(en)
|
2017-01-18 |
2023-01-17 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250799A0
(en)
|
2017-02-26 |
2017-04-30 |
The Nat Inst For Biotechnology In The Negev Ltd |
Soluble chimeras of dr3 and pro-pilot ether and their use
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
JP2020510023A
(ja)
|
2017-03-09 |
2020-04-02 |
ダイアメディカ, インコーポレイテッド |
組織カリクレイン1の剤形
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
EP3595687A1
(en)
|
2017-03-16 |
2020-01-22 |
Lineage Cell Therapeutics, Inc. |
Methods for measuring therapeutic effects of retinal disease therapies
|
BR112019020953A2
(pt)
|
2017-04-05 |
2020-05-05 |
Yeda Res & Dev |
sistema de cultura ex-vivo e métodos de uso do mesmo
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
CN110831966A
(zh)
|
2017-05-10 |
2020-02-21 |
阿里埃勒科学创新有限公司 |
纯化抗体的方法
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
WO2018216011A1
(en)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
US20200109408A1
(en)
|
2017-05-31 |
2020-04-09 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
JOP20190280A1
(ar)
|
2017-06-02 |
2019-12-02 |
Janssen Pharmaceutica Nv |
مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية
|
WO2018229767A1
(en)
|
2017-06-13 |
2018-12-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods for improving cell protein production yields
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
KR20200020888A
(ko)
|
2017-06-27 |
2020-02-26 |
얀센 파마슈티카 엔.브이. |
신규 퀴놀리논 화합물
|
US20200165671A1
(en)
|
2017-07-13 |
2020-05-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detecting tissue-specific dna
|
EP3652344A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Dna targets as tissue-specific methylation markers
|
US11466323B2
(en)
|
2017-07-13 |
2022-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
|
AU2018304618A1
(en)
|
2017-07-15 |
2020-03-05 |
Aleph Farms Ltd |
Cultured meat compositions
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
WO2019038771A1
(en)
|
2017-08-23 |
2019-02-28 |
Technion Research & Development Foundation Limited |
COMPOSITIONS AND METHODS FOR ENHANCING ALCOHOL TOLERANCE IN YEAST
|
US11332510B2
(en)
|
2017-09-18 |
2022-05-17 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Succinate-binding polypeptides and use thereof
|
US11555199B2
(en)
|
2017-09-19 |
2023-01-17 |
Tropic Biosciences UK Limited |
Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
|
EP3700856A4
(en)
|
2017-10-26 |
2021-12-15 |
Ultima Genomics, Inc. |
METHODS AND SYSTEMS FOR SEQUENCE CALL
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
CN111655690B
(zh)
|
2017-11-24 |
2023-01-10 |
詹森药业有限公司 |
吡唑并吡啶酮化合物
|
ES2963339T3
(es)
|
2017-11-24 |
2024-03-26 |
Janssen Pharmaceutica Nv |
Compuestos de pirazolopiridinona
|
AR114936A1
(es)
|
2017-11-29 |
2020-11-11 |
Weedout Ltd |
Composiciones, kits y métodos para controlar la maleza del género amaranthus
|
IL274979B2
(en)
|
2017-11-29 |
2024-07-01 |
Univ Ramot |
Methods for the prevention and treatment of neurogenic seizures
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
EP3723785A1
(en)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Cop9 signalosome (csn) complex modulators and uses thereof
|
WO2019130313A1
(en)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
KR20210126556A
(ko)
|
2018-01-25 |
2021-10-20 |
미아 리바이트 |
개선된 면역치료 방법
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
US20220128557A1
(en)
|
2018-02-08 |
2022-04-28 |
Phenofast Ltd. |
Appartatus and methods for real-time cell monitoring
|
EP3749689A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitors of the 20s proteasome
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
EP3752641A1
(en)
|
2018-02-18 |
2020-12-23 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Cell free dna deconvolution and use thereof
|
WO2019162945A1
(en)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(en)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Treatment of a heart disease
|
US11781183B2
(en)
|
2018-03-13 |
2023-10-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Diagnostic use of cell free DNA chromatin immunoprecipitation
|
CA3093647A1
(en)
|
2018-03-15 |
2019-09-19 |
Biond Biologics Ltd. |
Methods and compositions for decreasing soluble immune receptor cd28
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
WO2019186569A1
(en)
|
2018-03-29 |
2019-10-03 |
Yeda Research And Development Co. Ltd. |
Use of electric field gradients to control gene expression
|
IL314908A
(en)
|
2018-03-29 |
2024-10-01 |
Technion Res & Dev Foundation |
Bubbles containing PTEN inhibitor and their uses
|
EP3773677A1
(en)
|
2018-04-12 |
2021-02-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Anti-aging compositions and methods of use
|
EP3788626A1
(en)
|
2018-04-29 |
2021-03-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Method for selecting patient specific therapy
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
JP2021525233A
(ja)
|
2018-05-27 |
2021-09-24 |
バイオラインアールエックス・リミテッドBioLineRx Ltd. |
固形腫瘍を治療するためにチェックポイント阻害剤と併用するagi−134
|
US20210337753A1
(en)
|
2018-06-07 |
2021-11-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of regenerating and transforming cannabis
|
CN112424365A
(zh)
|
2018-06-07 |
2021-02-26 |
以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 |
核酸构建体及其使用方法
|
WO2020003311A1
(en)
|
2018-06-25 |
2020-01-02 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
US20210292381A1
(en)
|
2018-07-04 |
2021-09-23 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
EP3818529A2
(en)
|
2018-07-08 |
2021-05-12 |
Yeda Research and Development Co. Ltd |
Person-specific assessment of probiotics responsiveness
|
AU2019301316A1
(en)
|
2018-07-11 |
2021-02-18 |
Kahr Medical Ltd. |
Sirpalpha-4-1BBL variant fusion protein and methods of use thereof
|
WO2020012478A2
(en)
|
2018-07-11 |
2020-01-16 |
Immunity Pharma Ltd. |
Peptide compounds and therapeutic uses of same
|
AU2019315054A1
(en)
|
2018-07-31 |
2021-03-18 |
Collplant Ltd. |
Tobacco transgenic event and methods for detection and use thereof
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
EP3863637A1
(en)
|
2018-08-16 |
2021-08-18 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Treatment for gene reactivation
|
CN113227359A
(zh)
|
2018-08-24 |
2021-08-06 |
耶达研究及发展有限公司 |
调节m2巨噬细胞极化的方法及其在治疗中的用途
|
US20210353611A1
(en)
|
2018-09-20 |
2021-11-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral sclerosis
|
EA202190826A1
(ru)
|
2018-09-21 |
2021-06-16 |
Янссен Фармацевтика Нв |
Лечение холангиокарциномы
|
WO2020065647A1
(en)
|
2018-09-25 |
2020-04-02 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
WO2020069029A1
(en)
|
2018-09-26 |
2020-04-02 |
Emendobio Inc. |
Novel crispr nucleases
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
BR112021008808A2
(pt)
|
2018-11-08 |
2021-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Células independentes da ancoragem e utilização destas
|
US20210398673A1
(en)
|
2018-11-09 |
2021-12-23 |
The University Of Rochester |
Methods and systems for treating cancer based on response prediction using light scattering technology
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
AU2019389175A1
(en)
|
2018-11-30 |
2021-06-10 |
Caris Mpi, Inc. |
Next-generation molecular profiling
|
EP3902806A4
(en)
|
2018-12-26 |
2022-09-28 |
Janssen Pharmaceutica NV |
THIENOPYRIDINONE COMPOUNDS
|
EP3914698A1
(en)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
EP3927378A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
EP3927807A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
CN113692225B
(zh)
|
2019-03-05 |
2023-04-18 |
以色列农业和农村发展部农业研究组织(范卡尼中心) |
经基因组编辑的鸟类
|
BR112021017140A2
(pt)
|
2019-03-08 |
2021-11-09 |
Taro Pharma Ind |
Composições tópicas estáveis de fenoldopam
|
WO2020185790A1
(en)
|
2019-03-10 |
2020-09-17 |
Ultima Genomics, Inc. |
Methods and systems for sequence calling
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
CN113710704A
(zh)
|
2019-03-14 |
2021-11-26 |
比昂生物制剂公司 |
小脱落阻断剂
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
CA3130773A1
(en)
|
2019-03-29 |
2020-10-08 |
Peter Marie Z. De Porre |
Fgfr tyrosine kinase inhibitors for the treatment of urothelial carcinoma
|
CA3130460A1
(en)
|
2019-03-29 |
2020-10-08 |
Anne Elizabeth O'HAGAN |
Fgfr tyrosine kinase inhibitors for the treatment of urothelial carcinoma
|
WO2020202142A2
(en)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
EP3947728A1
(en)
|
2019-04-03 |
2022-02-09 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Primers for multiplex pcr
|
WO2020212992A2
(en)
|
2019-04-17 |
2020-10-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Cancer cell methylation markers and use thereof
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
EP3969619A1
(en)
|
2019-05-13 |
2022-03-23 |
Yeda Research and Development Co. Ltd |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
US20220213445A1
(en)
|
2019-05-22 |
2022-07-07 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
CA3141995A1
(en)
|
2019-06-12 |
2020-12-17 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
WO2020255124A1
(en)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
US20220251193A1
(en)
|
2019-06-27 |
2022-08-11 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
JP2022538647A
(ja)
|
2019-07-04 |
2022-09-05 |
ウッコ インコーポレイテッド |
脱エピトープ化されたアルファグリアジン、ならびにセリアック病およびグルテン過敏症の管理のためのその使用
|
CN114375310A
(zh)
|
2019-07-11 |
2022-04-19 |
卡尔医学有限公司 |
数个异二聚体及其数个使用方法
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
WO2021009740A1
(en)
|
2019-07-16 |
2021-01-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
CA3147575A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
US20220298522A1
(en)
|
2019-07-30 |
2022-09-22 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
BR112022002579A2
(pt)
|
2019-08-12 |
2022-06-14 |
Biond Biologics Ltd |
Anticorpos contra ilt2 e uso dos mesmos
|
WO2021028909A1
(en)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
GB201911928D0
(en)
|
2019-08-20 |
2019-10-02 |
Otsuka Pharma Co Ltd |
Pharmaceutical compounds
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
WO2021038569A1
(en)
|
2019-08-27 |
2021-03-04 |
Yeda Research And Development Co. Ltd. |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
JP2022548949A
(ja)
|
2019-09-23 |
2022-11-22 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
不安定なmRNAによって特徴付けられた遺伝性疾患の治療
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
GB201913921D0
(en)
|
2019-09-26 |
2019-11-13 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
MX2022005678A
(es)
|
2019-11-11 |
2022-10-18 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocuerpos para el control de insectos y usos de los mismos.
|
AU2019474716A1
(en)
|
2019-11-19 |
2022-07-07 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
WO2021112918A1
(en)
|
2019-12-02 |
2021-06-10 |
Caris Mpi, Inc. |
Pan-cancer platinum response predictor
|
CA3160220A1
(en)
|
2019-12-02 |
2021-06-10 |
Motti HAKIM |
Soluble cd28 levels during immunotherapy
|
WO2021130753A1
(en)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnosis of frontotemporal dementia
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
GB201919219D0
(en)
|
2019-12-23 |
2020-02-05 |
Otsuka Pharma Co Ltd |
Cancer biomarkers
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
JP2023510238A
(ja)
|
2020-01-02 |
2023-03-13 |
エディティ セラピューティクス リミテッド |
送達組成物および方法
|
IL272074B1
(en)
|
2020-01-15 |
2024-08-01 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
EP4096647A1
(en)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
IL295500A
(en)
|
2020-02-09 |
2022-10-01 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
TW202140012A
(zh)
|
2020-02-12 |
2021-11-01 |
比利時商健生藥品公司 |
用於治療尿路上皮癌的fgfr酪胺酸激酶抑制劑和抗pd1藥劑
|
BR112022015827A2
(pt)
|
2020-02-12 |
2022-10-04 |
Janssen Pharmaceutica Nv |
Inibidores de tirosina quinase de fgfr para o tratamento de câncer de bexiga invasivo não muscular de alto risco
|
WO2021181388A1
(en)
|
2020-03-09 |
2021-09-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing and treating p53 mutant cancer
|
CA3174444A1
(en)
|
2020-03-15 |
2021-09-23 |
Nanocarry Therapeutics Ltd. |
Nano-delivery system and therapeutic and diagnostic use thereof
|
EP4121441A1
(en)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
|
CA3174917A1
(en)
|
2020-03-29 |
2021-10-07 |
Yeda Research And Development Co. Ltd. |
Variants of beta-glucocerebrosidase for use in treating gaucher disease
|
EP4125440A1
(en)
|
2020-03-31 |
2023-02-08 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
EP4133107A1
(en)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
WO2021205459A1
(en)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
WO2021205453A1
(en)
|
2020-04-07 |
2021-10-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods for nucleic acid detection
|
US20230135456A1
(en)
|
2020-04-13 |
2023-05-04 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
WO2021209993A1
(en)
|
2020-04-13 |
2021-10-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of metabolic regulators for the treatment of covid-19
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
EP4142702A1
(en)
|
2020-05-01 |
2023-03-08 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
E protein channel blockers and orf3 inhibitors as anti-covid-19 agents
|
WO2022113069A1
(en)
|
2020-11-24 |
2022-06-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
E protein channel blockers and orf3 inhibitors as anti-covid-19 agents
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
EP4168438A4
(en)
|
2020-06-22 |
2024-07-10 |
Univ Ramot |
MULTIPLE SUBUNIT PROTEIN MODULES, CELLS FOR EXPRESSING THEM AND USES THEREOF
|
WO2021260675A1
(en)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
WO2022013874A1
(en)
|
2020-07-14 |
2022-01-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising cannabinoids, terpenes, and flavonoids for treating depression
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
KR20230058074A
(ko)
|
2020-08-12 |
2023-05-02 |
비온드 바이오로직스 엘티디 |
Ilt2에 대한 항체 및 이의 용도
|
WO2022038536A1
(en)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
JP2023539867A
(ja)
|
2020-08-27 |
2023-09-20 |
大塚製薬株式会社 |
Mdm2アンタゴニストを用いた癌治療に関するバイオマーカー
|
MX2023002980A
(es)
|
2020-09-14 |
2023-06-06 |
Janssen Pharmaceutica Nv |
Terapias de combinación de inhibidores del fgfr.
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(en)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating coronaviral infections
|
GB202015187D0
(en)
|
2020-09-25 |
2020-11-11 |
Sentinel Oncology Ltd |
A pharmaceutical salt
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
CN116635056A
(zh)
|
2020-10-07 |
2023-08-22 |
波塔力克斯有限公司 |
长效脱氧核糖核酸酶
|
WO2022079719A1
(en)
|
2020-10-15 |
2022-04-21 |
Yeda Research And Development Co. Ltd. |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
IL302594A
(en)
|
2020-11-09 |
2023-07-01 |
1E Therapeutics Ltd |
Methods based on catalytic sequences for the treatment or prevention of bacterial infections
|
US20230416314A1
(en)
|
2020-11-26 |
2023-12-28 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
WO2022144883A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna targeting dnazymes
|
AU2021411103A1
(en)
|
2020-12-28 |
2023-07-13 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
WO2022144903A1
(en)
|
2021-01-03 |
2022-07-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Cancer driver mutation diagnostics
|
EP4274886A2
(en)
|
2021-01-10 |
2023-11-15 |
Supermeat the Essence of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
WO2022157772A1
(en)
|
2021-01-21 |
2022-07-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Rnai nanoparticles and methods of using same in agriculture
|
IL305315A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
Methods for producing vaccines
|
WO2022175951A1
(en)
|
2021-02-18 |
2022-08-25 |
Yeda Research And Development Co. Ltd. |
Genetically modified bacteria for generating vaccines
|
GB202103080D0
(en)
|
2021-03-04 |
2021-04-21 |
Otsuka Pharma Co Ltd |
Cancer biomarkers
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
JP2024514252A
(ja)
|
2021-03-30 |
2024-03-29 |
バイオエムエックス・リミテッド |
Pseudomonasバクテリオファージ及びその使用
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
EP4326332A1
(en)
|
2021-04-20 |
2024-02-28 |
Biond Biologics Ltd. |
Intracellular delivery compositions
|
EP4337764A1
(en)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
BR112023023935A2
(pt)
|
2021-05-19 |
2024-01-30 |
Janssen Pharmaceutica Nv |
Inibidores de tirosina quinase de fgfr para o tratamento de tumores sólidos avançados
|
US20240241139A1
(en)
|
2021-05-25 |
2024-07-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Diagnosis of autism spectrum disorder by multiomics platform
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
WO2022259242A1
(en)
|
2021-06-06 |
2022-12-15 |
Yeda Research And Development Co. Ltd. |
Combined treatment for cancer
|
AU2022294310A1
(en)
|
2021-06-13 |
2024-05-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming human cells
|
KR20240035997A
(ko)
|
2021-06-16 |
2024-03-19 |
시드엑스 테크놀로지스 인코포레이티드 |
마티올라 종자들을 선별하는 방법들
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
WO2023275590A1
(en)
|
2021-06-29 |
2023-01-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detection of phosphoinositides in blood cells as a biomarker for alpha synuclein associated pathologies and a method of treatment of parkinson's disease and the related neurodegenerations
|
JP2024524924A
(ja)
|
2021-07-02 |
2024-07-09 |
トロピック バイオサイエンシーズ ユーケー リミテッド |
バナナ果実における褐変の遅延又は防止
|
EP4373919A1
(en)
|
2021-07-18 |
2024-05-29 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
KR20240040770A
(ko)
|
2021-08-03 |
2024-03-28 |
제니시티 리미티드 |
조작된 tcr 복합체 및 이의 사용 방법
|
GB202111193D0
(en)
|
2021-08-03 |
2021-09-15 |
Phoremost Ltd |
Pharmaceutical compounds
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
US20240358828A1
(en)
|
2021-08-10 |
2024-10-31 |
Gamida Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
AU2022341016A1
(en)
|
2021-09-06 |
2024-04-18 |
Biond Biologics Ltd. |
Cd28 shedding blocking agents
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
US20240350485A1
(en)
|
2021-10-12 |
2024-10-24 |
Taris Biomedical Llc |
Erdafitinib formulations and systems for intravesical administration
|
IL287372A
(en)
|
2021-10-18 |
2023-05-01 |
Trojan Bio Ltd |
Bifunctional antigen-related molecules
|
IL312140A
(en)
|
2021-10-18 |
2024-06-01 |
Belgian Volition Srl |
Using nanoporous tiling to determine the source of DNA in the bloodstream
|
KR20240147737A
(ko)
|
2021-11-03 |
2024-10-08 |
비온드 바이오로직스 엘티디 |
세포내 전달 조성물
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
EP4448101A1
(en)
|
2021-12-15 |
2024-10-23 |
Immunyx Pharma Ltd. |
Neutrophil exocytosis inhibitors
|
IL313936A
(en)
|
2021-12-26 |
2024-08-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods for screening and treating fragile X syndrome
|
WO2023148732A1
(en)
|
2022-02-01 |
2023-08-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for selecting an improved genetically modified plant
|
IL314899A
(en)
|
2022-02-16 |
2024-10-01 |
Yeda Res & Dev |
Methods for shortening the duration of the lag phase in microorganisms
|
KR20240145513A
(ko)
|
2022-02-18 |
2024-10-07 |
타리스 바이오메디컬 엘엘씨 |
에르다피티닙 제형 및 방광내 투여를 위한 삼투성 시스템
|
WO2023195009A1
(en)
|
2022-04-07 |
2023-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Genetically modified bacteria and use thereof
|
WO2023209716A1
(en)
|
2022-04-25 |
2023-11-02 |
Biond Biologics Ltd. |
Anti-ilt3 antibodies and use thereof
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023214405A1
(en)
|
2022-05-01 |
2023-11-09 |
Yeda Research And Development Co. Ltd. |
Reexpression of hnf4a to alleviate cancer-associated cachexia
|
WO2023218450A1
(en)
|
2022-05-09 |
2023-11-16 |
Yeda Research And Development Co. Ltd. |
A commensal fungus and uses thereof
|
WO2023233413A1
(en)
|
2022-06-01 |
2023-12-07 |
Yeda Research And Development Co. Ltd. |
eIF4G1-eIF1 INHIBITORS AND USE THEREOF
|
WO2023238131A1
(en)
|
2022-06-07 |
2023-12-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of treating x-linked genetic diseases
|
WO2023248220A1
(en)
|
2022-06-20 |
2023-12-28 |
Yeda Research And Development Co. Ltd. |
Particles comprising double stranded rna and use of same in agriculture
|
WO2024013742A1
(en)
|
2022-07-11 |
2024-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Improving adoptive cell transfer therapy (act) treatment
|
WO2024038457A1
(en)
|
2022-08-18 |
2024-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A method for determining the tissue or cell of origin of dna
|
IL300306A
(en)
|
2023-01-30 |
2024-08-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods for immunotherapy targeted against CD48
|
WO2024170495A1
(en)
|
2023-02-13 |
2024-08-22 |
Janssen Pharmaceutica Nv |
Fgfr tyrosine kinase inhibitors for the treatment of high-risk non-muscle invasive bladder cancer
|
WO2024173377A1
(en)
|
2023-02-13 |
2024-08-22 |
Taris Biomedical Llc |
Erdafitinib for intravesical administration for use in the treatment of bladder cancer
|
WO2024173716A1
(en)
|
2023-02-17 |
2024-08-22 |
Taris Biomedical Llc |
Erdafitinib for intravesical administration for use in the treatment of bladder cancer
|